BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27186920)

  • 1. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
    Song W; Zhang RJ; Zou SB
    Minerva Med; 2016 May; ():. PubMed ID: 27186920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
    Song W; Zhang RJ; Zou SB
    Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis.
    Shuai P; Zhou Y; Gong B; Jiang Z; Yang C; Yang H; Zhang D; Zhu S
    Springerplus; 2016; 5(1):1721. PubMed ID: 27777857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of long noncoding RNA MALAT1 in digestive system malignancies.
    Zhai H; Li XM; Maimaiti A; Chen QJ; Liao W; Lai HM; Liu F; Yang YN
    Int J Clin Exp Med; 2015; 8(10):18099-106. PubMed ID: 26770406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
    Xue Y; Teng YQ; Zhou JD; Rui YJ
    Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long noncoding RNA MALAT1: a potential novel prognostic biomarkers in cancers based on Meta-analysis].
    Song W; Wang K; Zhang R; Zou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1163-1167. PubMed ID: 27932761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis.
    Li J; Cui Z; Li H; Lv X; Gao M; Yang Z; Bi Y; Zhang Z; Wang S; Zhou B; Yin Z
    Cancer Cell Int; 2018; 18():109. PubMed ID: 30093838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of long non-coding RNA MALAT1 in cancer patients.
    Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D
    Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of long non-coding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A meta-analysis.
    Wang C; Zhang Q; Hu Y; Zhu J; Yang J
    Oncol Lett; 2019 Feb; 17(2):2159-2170. PubMed ID: 30719108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
    Wei Y; Niu B
    Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prognostic value of metastasis-associated lung adenocarcinoma transcript 1 in various human cancers: an updated meta-analysis.
    Li Y; Yang Z; Wan X; Zhou J; Zhang Y; Ma H; Bai Y
    Int J Biol Markers; 2016 May; 31(2):e173-82. PubMed ID: 26847605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
    Tian X; Xu G
    BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis.
    Zhang J; Zhang B; Wang T; Wang H
    Int J Clin Exp Med; 2015; 8(4):5499-505. PubMed ID: 26131129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
    Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of the long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in various cancers: A meta-analysis.
    Yan J; Zhou X; Dang Y; Yin C; Zhang G
    Mol Clin Oncol; 2016 Jan; 4(1):100-106. PubMed ID: 26870366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of the clinicopathological significance of the lncRNA MALAT1 in human gastric cancer.
    Bai S; Guo J; Zhang H
    Front Oncol; 2023; 13():1257120. PubMed ID: 38239645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
    Su Y; Chen H; Yao L; Dai H; Liu H
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):166-171. PubMed ID: 38279449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis.
    Cheng XB; Fu B; Li XZ; Jiang Y
    Pathol Res Pract; 2020 Jun; 216(6):152949. PubMed ID: 32307201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis.
    Liu X; Ming X; Jing W; Luo P; Li N; Zhu M; Yu M; Liang C; Tu J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.